EndoGastric Solutions Competitors, Revenue, Alternatives and Pricing

Claim your profile

Overview

Location:
Seattle, WA USA
Total Funding:N/A
Industry:Medical Equip
Founded:2003
Lead Investor(s):N/A

City Ranking

Industry Ranking

State Ranking

Growjo 10k Ranking

Estimated Revenue & Financials

  • EndoGastric Solutions's estimated annual revenue is currently $19.1M per year.(?)
  • EndoGastric Solutions's estimated revenue per employee is $251,000

Employee Data

  • EndoGastric Solutions has 76 Employees.(?)
  • EndoGastric Solutions grew their employee count by 4% last year.
  • EndoGastric Solutions currently has 1 job openings.

About EndoGastric Solutions: Based in Redmond, WA, EndoGastric Solutions, Inc. (www.endogastricsolutions.com), is a medical device company focused on developing and commercializing innovative, evidence-based, incisionless surgical technology for the treatment of gastroesophageal reflux disease (GERD). EGS has combined the most advanced concepts in gastroenterology and surgery to develop the Transoral Incisionless Fundoplication (TIF®) procedure—a barely invasive solution that addresses a significant unmet clinical need. About Transoral Incisionless Fundoplication (TIF®) procedure for reflux: Performed without the need for external incisions through the skin, the TIF procedure offers patients who require an anatomical repair another treatment option to correct the underlying cause of GERD. Studies show that for up to three years after the TIF procedure esophageal inflammation (esophagitis) is eliminated and most patients are able to stop using daily PPI medications to control symptoms. To locate a physician visit GERDHelp.com. About EsophyX® technology: The original EsophyX device was cleared by the FDA in 2007. EGS launched the third generation EsophyX device, the EsophyX Z in 2015. The technology has continued to evolve and is a clinically-backed tool for physician use in the treatment of GERD. The EsophyX technology now enables surgeons and gastroenterologists to use a wider selection of endoscopes–including low profile and larger high-definition models—to treat the underlying anatomical cause of GERD. The EsophyX technology is used to reconstruct the gastroesophageal valve (GEV) and restore its function as a barrier, preventing stomach acids from washing back up into the esophagus. The device is inserted through the patient’s mouth with direct visual guidance from an endoscope.

keywords:N/A